CN Patent
CN109966277B — 一种治疗难治性癫痫的药物组合物及其应用
Assigned to AFFILIATED HOSPITAL OF JINING MEDICAL UNIVERSITY · Expires 2021-04-30 · 5y expired
What this patent protects
本发明公开了一种治疗难治性癫痫的药物组合物及其应用,该药物组合物的活性成分的组成为:(1)丙戊酸钠或双丙戊酸钠;和(2)乙胺丁醇或其可药用盐。本发明首次发现低剂量盐酸乙胺丁醇具有抗癫痫作用,并且将该药物与丙戊酸钠或双丙戊酸钠用于难治性癫痫的治疗,其抗癫痫效果显著,同时毒副作用明显降低。
USPTO Abstract
本发明公开了一种治疗难治性癫痫的药物组合物及其应用,该药物组合物的活性成分的组成为:(1)丙戊酸钠或双丙戊酸钠;和(2)乙胺丁醇或其可药用盐。本发明首次发现低剂量盐酸乙胺丁醇具有抗癫痫作用,并且将该药物与丙戊酸钠或双丙戊酸钠用于难治性癫痫的治疗,其抗癫痫效果显著,同时毒副作用明显降低。
Drugs covered by this patent
- Sinemet Cr (CARBIDOPA) · Aton
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.